Non-human primate studies suggest that MDMA may not be as neurotoxic as previously believed, challenging the narrative established by earlier rodent research. A pivotal 2002 study raised alarms about the drug's effects, leading to debates over its potential legalization for PTSD treatment. The scrutiny surrounding this research highlights the ongoing tension between scientific findings and regulatory perspectives.
